Yuya Mizuno

2.6k total citations · 2 hit papers
35 papers, 1.7k citations indexed

About

Yuya Mizuno is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Yuya Mizuno has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 6 papers in Pharmacology. Recurrent topics in Yuya Mizuno's work include Schizophrenia research and treatment (21 papers), Bipolar Disorder and Treatment (11 papers) and Mental Health Treatment and Access (5 papers). Yuya Mizuno is often cited by papers focused on Schizophrenia research and treatment (21 papers), Bipolar Disorder and Treatment (11 papers) and Mental Health Treatment and Access (5 papers). Yuya Mizuno collaborates with scholars based in Japan, United Kingdom and Austria. Yuya Mizuno's co-authors include Oliver Howes, Robert A. McCutcheon, Abhishekh H. Ashok, Toby Pillinger, Luke Vano, Sridhar Natesan, Nora D. Volkow, Katherine Beck, Orestis Efthimiou and Andrea Cipriani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neuropsychopharmacology.

In The Last Decade

Yuya Mizuno

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis

2019 614 citations Toby Pillinger, Robert A. McCutcheon et al. The Lancet Psychiatry profile →
Glucagon-Like Peptide 1 Receptor Agonists and Mental Health

2025 18 citations Yuya Mizuno, Oliver Howes et al. profile →

Peers

Yuya Mizuno

PMH

PHYSI

CMN

EDM

Jingping Zhao China

Jacob S. Ballon United States

Marina Šagud Croatia

Richard Musil Germany

Ross A. Baker United States

Martin Strassnig United States

Clemente García‐Rizo Spain

Petter Andreas Ringen Norway

Nadja P. Marić Serbia

Douglas L. Boggs United States

Jingping Zhao China

Yuya Mizuno

749 ×0.8

PMH

315 ×0.9

322 ×1.3

PHYSI

112 ×0.5

CMN

255 ×1.2

EDM

Citations per year, relative to Yuya Mizuno Yuya Mizuno (= 1×) peers Jingping Zhao

Countries citing papers authored by Yuya Mizuno

Since Specialization

Citations

This map shows the geographic impact of Yuya Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuya Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuya Mizuno more than expected).

Fields of papers citing papers by Yuya Mizuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuya Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuya Mizuno. The network helps show where Yuya Mizuno may publish in the future.

Co-authorship network of co-authors of Yuya Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Yuya Mizuno. A scholar is included among the top collaborators of Yuya Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuya Mizuno. Yuya Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mizuno, Yuya, Tiago Reis Marques, Julia Schubert, et al.. (2025). MICROGLIAL ACTIVATION IN MEDICATED PATIENTS WITH FIRST-EPISODE PSYCHOSIS: PRELIMINARY RESULTS FROM A [18F]DPA-714 PET IMAGING STUDY. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i233–i233.

Mizuno, Yuya, et al.. (2025). Likelihood-Scheduled Score-Based Generative Modeling for Fully 3D PET Image Reconstruction. IEEE Transactions on Medical Imaging. 44(11). 4445–4456.

Misawa, Fuminari, et al.. (2024). Intentional non-adherence to antipsychotic medication in patients with schizophrenia. Schizophrenia Research. 274. 427–432.

Arumuham, Atheeshaan, et al.. (2024). Immune response to vaccination in people with psychotic disorders relative to healthy controls: prospective study of SARS-CoV-2 vaccination. BJPsych Open. 10(2). e49–e49. 1 indexed citations

Mizuno, Yuya, et al.. (2023). Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies. Journal of Psychopharmacology. 37(11). 1058–1069. 21 indexed citations

So, Ryuhei, Fuminari Misawa, Manabu Kodama, et al.. (2022). Clozapine Once-Daily Versus Divided Dosing Regimen: A Cross-sectional Study in Japan.. PubMed. 42(2). 163–168. 1 indexed citations

So, Ryuhei, Yuya Mizuno, Fuminari Misawa, et al.. (2020). Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J). PLoS ONE. 15(6). e0234864–e0234864. 4 indexed citations

Guo, Xin, Robert A. McCutcheon, Toby Pillinger, et al.. (2020). The magnitude and heterogeneity of antidepressant response in depression: A meta-analysis of over 45,000 patients. Journal of Affective Disorders. 276. 991–1000. 14 indexed citations

McCutcheon, Robert A., Toby Pillinger, Yuya Mizuno, et al.. (2019). The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis. Molecular Psychiatry. 26(4). 1310–1320. 57 indexed citations

10.

Mizuno, Yuya, Robert A. McCutcheon, Stefan Brugger, & Oliver Howes. (2019). Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis. Neuropsychopharmacology. 45(4). 622–631. 68 indexed citations

11.

Pillinger, Toby, Robert A. McCutcheon, Luke Vano, et al.. (2019). Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. The Lancet Psychiatry. 7(1). 64–77. 614 indexed citations breakdown →

12.

Sawada, Kyosuke, Kazunari Yoshida, Yuya Mizuno, et al.. (2018). Impact of subjective vs. objective remission status on subjective cognitive impairments in depression. Journal of Affective Disorders. 246. 99–104. 10 indexed citations

13.

Suzuki, Takefumi, Yuya Mizuno, Ryosuke Tarumi, et al.. (2017). Resilience and spirituality in patients with depression and their family members: A cross-sectional study. Comprehensive Psychiatry. 77. 53–59. 39 indexed citations

14.

Uchida, Hiroyuki, Yuya Mizuno, Hideaki Tani, et al.. (2017). Effects of chair yoga therapy on physical fitness in patients with psychiatric disorders: A 12-week single-blind randomized controlled trial. Journal of Psychiatric Research. 94. 194–201. 28 indexed citations

15.

Hofer, Alex, Yuya Mizuno, Fabienne Wartelsteiner, et al.. (2017). Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience. European Psychiatry. 46. 42–47. 47 indexed citations

16.

Mizuno, Yuya, Fabienne Wartelsteiner, & Beatrice Frajo-Apor. (2016). Resilience research in schizophrenia. Current Opinion in Psychiatry. 29(3). 218–223. 29 indexed citations

17.

Mizuno, Yuya, Alex Hofer, Takefumi Suzuki, et al.. (2016). Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study. Schizophrenia Research. 175(1-3). 148–153. 57 indexed citations

18.

Yoshida, Kazunari, Robert R. Bies, Takefumi Suzuki, et al.. (2014). Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data. Schizophrenia Research. 153(1-3). 184–188. 19 indexed citations

19.

Mizuno, Yuya, Takefumi Suzuki, Atsuo Nakagawa, et al.. (2014). Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia Bulletin. 40(6). 1385–1403. 144 indexed citations

20.

Mizuno, Yuya, Robert R. Bies, Gary Remington, et al.. (2011). Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: A cross-sectional study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 37(1). 182–187. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact